Invitrogen™ Human EPM2A Synthetic Peptide

Catalog No.	Quantity
PEP1478	50 μg

Catalog No. PEP1478 Supplier Invitrogen™ Supplier No. PEP1478

Description

Synthetic Peptide

EPM2A Synthetic Peptide, PEP-1478, from Invitrogen.

The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.

Specifications

• Gene ID (Entrez): 7957
• Species: Human
• Purification Method: purified
• Accession Number: B3EWF7
• Common Name: Human EPM2A
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: EPM2A
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS